Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice von BRUYNZEEL, A. M. E, ABOU EL HASSAN, M. A, SCHALKWIJK, C, BERKHOF, J, BAST, A, NIESSEN, H. W. M, VAN DER VIJGH, W. J. F

Volltext

PPI use is not associated with bone microarchitecture and strength assessed with HR-pQCT after three-years follow-up in patients visiting the Fracture Liaison Service von Schene, M.R., Bevers, M.S.A.M., van der Vijgh, W.J.F., Driessen, J.H.M., Vranken, L., van der Velde, R.Y., Willems, H.C., Wyers, C.E., van den Bergh, J.P.

Volltext

Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells von BRUYNZEEL, A. M. E, ABOU EL HASSAN, M. A, TORUN, E, BAST, A, VAN DER VIJGH, W. J. F, KRUYT, F. A. E

Volltext

The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study von BRUYNZEEL, A. M. E, NIESSEN, H. W. M, BRONZWAER, J. G. F, VAN DER HOEVEN, J. J. M, BERKHOF, J, BAST, A, VAN DER VIJGH, W. J. F, VAN GROENINGEN, C. J

Volltext

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines von VAN MOORSEL, C. J. A, PINEDO, H. M, VEERMAN, G, BERGMAN, A. M, KUIPER, C. M, VERMORKEN, J. B, VAN DER VIJGH, W. J. F, PETERS, G. J

Volltext

Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer von KROEP, J. R, SMIT, E. F, GIACCONE, G, VAN DER BORN, K, BEIJNEN, J. H, VAN GROENINGEN, C. J, VAN DER VIJGH, W. J. F, POSTMUS, P. E, PINEDO, H. M, PETERS, G. J

Volltext

Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors von Giaccone, G., González-Larriba, J. L., van Oosterom, A. T., Alfonso, R., Smit, E. F., Martens, M., Peters, G. J., van der Vijgh, W. J. F., Smith, R., Averbuch, S., Fandi, A.

Volltext

The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro von ABOU EL HASSAN, Mai, VERHEUL, H. M. W, JORNA, A. S, SCHALKWIJK, C, VAN BEZU, J, VAN DER VIJGH, W. J. F, BAST, A

Volltext

Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats von VERSCHRAAGEN, M, BOVEN, E, TORUN, E, ERKELENS, C. A. M, HAUSHEER, F. H, VAN DER VIJGH, W. J. F

Volltext

The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB von Jacobs, H, Bast, A, Peters, G J, van der Vijgh, W J F, Haenen, G R M M

Volltext

Protectors against doxorubicin-induced cardiotoxicity: flavonoids von Bast, A, Kaiserová, H, den Hartog, G J M, Haenen, G R M M, van der Vijgh, W J F

Volltext

Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo von WELTERS, M. J. P, FICHTINGERCONEPHIAN, A. M. J, BAAN, R. A, JACOBS-BERGMANS, A. J, KEGEL, A, VAN DER VIJGH, W. J. F, BRAAKHUIS, B. J. M

Volltext

Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups von Heijnen, C.G.M, Haenen, G.R.M.M, van Acker, F.A.A, van der Vijgh, W.J.F, Bast, A

Volltext

The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured ce... von Abou El Hassan, M A I, Heijn, M, Rabelink, M J W E, van der Vijgh, W J F, Bast, A, Hoeben, R C

Volltext

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule von BOVEN, E, WESTERMAN, M, VAN GROENINGEN, Cj, VERSCHRAAGEN, M, RUIJTER, R, ZEGERS, I, VAN DER VIJGH, Wjf, GIACCONE, G

Volltext

A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro von MAI ABOU EL HASSAN, RABELINK, M. J. W. E, VAN DER VIJGH, W. J, BAST, A, HOEBEN, R. C

Volltext

Influence of iron chelation on the antioxidant activity of flavonoids von van Acker, Saskia A.B.E, van Balen, Georgette Plemper, van den Berg, Dirk–Jan, Bast, Aalt, van der Vijgh, Wim J.F

Volltext

Altered Pharmacokinetics and Metabolism of CPT-11 in Liver Dysfunction: A Need for Guidelines von VAN GROENINGEN, C. J, VAN DER VIJGH, W. J. F, BAARS, J. J, STIELTJES, H, HUIBREGTSE, K, PINEDO, H. M

Volltext

Lack of inhibition of endothelial nitric oxide synthase in the isolated rat aorta by doxorubicin von den Hartog, G.J.M., Boots, A.W., Haenen, G.R.M.M., van der Vijgh, W.J.F., Bast, A.

Volltext

The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor- B von Jacobs, H, Bast, A, Peters, G J, Van Der Vijgh, W J F, Haenen, G R M M

Volltext